Cognitive function
Magnesium at around 600 mg/day reduced migraine attack frequency compared with placebo in randomised trials, and several headache guidelines include it as a low-risk option. Trials are relatively few, results are not uniform, and the dose exceeds the supplemental upper limit.
What may be going on: Magnesium modulates NMDA receptor activity and cortical spreading depression, both implicated in migraine pathophysiology.
Moderate evidence. Several human studies point the same way, with real caveats.
View the 4 sources
- Effects of selected dietary supplements on migraine prophylaxis: A systematic review and dose-response meta-analysis of randomized controlled trials.(opens in a new tab)
Meta-analysis · Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2025 · PMID 39404918
- Magnesium in Migraine Prophylaxis-Is There an Evidence-Based Rationale? A Systematic Review.(opens in a new tab)
Systematic review · Headache · 2018 · PMID 29131326
- Effects of Intravenous and Oral Magnesium on Reducing Migraine: A Meta-analysis of Randomized Controlled Trials.(opens in a new tab)
Meta-analysis · Pain physician · 2016 · PMID 26752497
- Tocolytics for delaying preterm birth: a network meta-analysis (0924).(opens in a new tab)
Systematic review · The Cochrane database of systematic reviews · 2022 · PMID 35947046
Deep research mode adds each paper’s own conclusion and stated limitations.